Literature DB >> 19019706

Etiology of a short-term mortality in the group of 750 patients with 920 episodes of status epilepticus within a period of 10 years (1988-1997).

D V Sokic1, S M Jankovic, N M Vojvodic, A J Ristic.   

Abstract

PURPOSE: To determine the etiology of short-term mortality in patients with status epilepticus (SE).
METHODS: 920 episodes of SE were recorded among 750 patients in a 10-year period. According to the clinical assessment, sequence of events that led to death in a particular case showed two major causes of death: (1) underlying disease, and (2) complications caused by convulsions, therapy or coma.
RESULTS: Among 920 episodes of SE, 120 (13%) patients passed away. 79 patients (65.8%) died due to the underlying disease and 27 patients (22.5%) died of the combination caused by complications of underlying disease, convulsions, therapy, and/or coma. Among remaining 14 patients (11.7%), underlying disease was not the cause of death. Those 14 patients suffered complications caused by convulsions, therapy, and coma which caused death in four; therapy and coma in three; therapy in three; coma in two; and convulsions and coma in two patients, in the order already mentioned.
CONCLUSIONS: Among approximately 9 out of 10 patients with SE, death was the result of underlying disease. Although with very few patients, additional factors could provoke fatal complications of SE. In case of 1 among 10 patients complications caused by coma, therapy, and/or convulsions were the immediate cause of death. In case of such patients timely and adequate treatment could prevent death.

Entities:  

Mesh:

Year:  2008        PMID: 19019706     DOI: 10.1016/j.seizure.2008.10.002

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  7 in total

Review 1.  Treatment of Refractory and Super-refractory Status Epilepticus.

Authors:  Samhitha Rai; Frank W Drislane
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

2.  Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study.

Authors:  Raoul Sutter; Stephan Marsch; Peter Fuhr; Peter W Kaplan; Stephan Rüegg
Journal:  Neurology       Date:  2013-12-06       Impact factor: 9.910

3.  Epidemiology-based mortality score in status epilepticus (EMSE).

Authors:  M Leitinger; Y Höller; G Kalss; A Rohracher; H F Novak; J Höfler; J Dobesberger; G Kuchukhidze; E Trinka
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

4.  Therapeutic coma for status epilepticus: Differing practices in a prospective multicenter study.

Authors:  Vincent Alvarez; Jong Woo Lee; M Brandon Westover; Frank W Drislane; Jan Novy; Mohamed Faouzi; Nicola A Marchi; Barbara A Dworetzky; Andrea O Rossetti
Journal:  Neurology       Date:  2016-09-24       Impact factor: 9.910

Review 5.  Pharmacotherapy for Status Epilepticus.

Authors:  Eugen Trinka; Julia Höfler; Markus Leitinger; Francesco Brigo
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

6.  Predictive value of the Status Epilepticus Severity Score (STESS) and its components for long-term survival.

Authors:  Preben Aukland; Martin Lando; Ole Vilholm; Elsebeth Bruun Christiansen; Christoph Patrick Beier
Journal:  BMC Neurol       Date:  2016-11-05       Impact factor: 2.474

7.  Outcomes of patients with altered level of consciousness and abnormal electroencephalogram: A retrospective cohort study.

Authors:  Paula Rodrigues Sanches; Thiago Domingos Corrêa; Taissa Ferrari-Marinho; Pedro Vicente Ferreira Naves; Carol Ladeia-Frota; Luís Otávio Caboclo
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.